Edmond de Rothschild Fund Healthcare A EUR/  LU1160356009  /

The objective of the Product is to outperform its benchmark by investing in companies operating in the healthcare sector, that meet environmental, social and governance (ESG) criteria. The Product exposes at least 75% of its net assets in/to securities issued by companies operating the healthcare sector (biotechnology, pharmaceuticals, medical technology, medical diagnosis, hospital and healthcare center management, and other medical services) as well as companies marketing these products or services. Between 75% and 110% of the Product's net assets will be exposed (directly or indirectly) to the international equity markets and other assimilated securities: directly, via UCIs and/or financial contracts. The Product aims at selecting companies operating in the healthcare sector, with a focus on a good management of environmental, social, and governance (ESG) risks and opportunities. The Product's investment process entails, to this aim, a proprietary responsible investing approach which favours ESG well rated companies irrespective of their capitalizations and relying on either a proprietary ESG rating or a rating provided by an external extra-financial rating agency. At least 90% of portfolio companies receive ESG rating.

The objective of the Product is to outperform its benchmark by investing in companies operating in the healthcare sector, that meet environmental, social and governance (ESG) criteria.